Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

sanofi-aventis reports 2009 fourth-quarter and full-year net earnings

Commenting on the Group's 2009 performance, sanofi-aventis Chief Executive Officer Christopher A. Viehbacher said, "2009 was the first year of implementation of our new strategy. Major steps have already been achieved in strengthening our growth platforms and reinforcing our R&D pipeline while delivering a double-digit EPS(1) growth".

10 Feb 2010

Bombarding DNA nucleotides and mammalian meat with ‘femto-neutrons’ open new path to femtomedicine

Bombarding DNA nucleotides and mammalian meat with ‘femto-neutrons’ has opened up the path to femtomedicine, an entirely new cancer diagnostics, it was reported today at First Global Congress on NanoEngineering for Medicine and Biology in Houston, TX.

10 Feb 2010

Age-related gaps in care and outcomes for stroke patients are diminishing in hospitals

Age-related gaps in care and outcomes for stroke patients are diminishing as hospitals improve adherence to evidence-based treatments of the American Heart Association/American Stroke Association's Get With The Guidelines–Stroke initiative, according to a new study in Circulation: Journal of the American Heart Association.

10 Feb 2010

QR Pharma commences clinical trial of Posiphen in early stage AD patients

QR Pharma, Inc. , a developer of novel drugs to treat Alzheimer’s disease, announced today that it began a clinical trial of its lead compound, Posiphen, in early stage AD patients.

10 Feb 2010

American Heart Month: Spread awareness on dangers of heart disease and stroke

American Heart Month is a time to spread awareness of the dangers of heart disease and stroke, and recommit to strengthening prevention, improving treatments, and helping all Americans live longer, healthier lives.

10 Feb 2010

Study calls for improved decision-making in using feeding tubes in dementia patients

Researchers from Brown University and Harvard Medical School are calling for improved decision-making in the use of feeding tubes for hospitalized nursing home residents with advanced dementia.

10 Feb 2010

Concomitant use of dexlansoprazole and other PPIs with Plavix: TGRD U.S. initiates trial

Takeda Global Research & Development Center, Inc., U.S., (TGRD U.S.) announced today that it has initiated a trial to study how dexlansoprazole and several other proton pump inhibitors (PPIs) affect the pharmacokinetics and pharmacodynamics of Plavix (clopidogrel bisulfate) in healthy subjects. Takeda has been evaluating all published data and communications from the U.S. Food and Drug Administration (FDA) regarding the potential risks associated with concomitant use of clopidogrel and PPIs.

10 Feb 2010

Racial gaps persist in women's heart-health awareness

Racial gaps exist in women's heart-health awareness, women's knowledge of heart attack warning signs requires attention and nearly half of women report they would not call 9-1-1 if they were having heart attack symptoms, according to new research published in Circulation: Cardiovascular Quality and Outcomes, a journal of the American Heart Association.

10 Feb 2010

SMT Research and Development completes first two clinical cases using Shimon Embolic Filter

SMT Research and Development, Ltd., a privately held company, announced that it has completed its first two clinical cases using the Shimon Embolic Filter [SHEF] (TM). SMT R&D developed a novel technology for brain protection (Neuroprotection) from stroke complication hazards arising from invasive cardiology procedures and heart surgery.

10 Feb 2010

An inspirational story from stroke survivor

A new Jeff Kagan Report & Comment discusses Life After Stroke. Jeff Kagan has been one of the most well-known voices in the wireless and telecom industry for the past 25 years. Five years ago he had a stroke that changed his life and took him out of the game for a while.

10 Feb 2010

Concentric Medical's Trevo System receives regulatory approval in Europe and Canada

Concentric Medical, Inc., the global leader in acute ischemic stroke intervention, today announced that its Trevo System for acute ischemic stroke has received regulatory approval in both Europe (CE Mark) and Canada.

10 Feb 2010

Maternal obesity increases offspring's risk of developing inflammation-related disorders

As if there are not enough reasons for obese people to lose weight, a new research report published online in The FASEB Journal (http://www.fasebj.org), adds several more. In a study involving rats, researchers from Duke University found that obesity in mothers causes cellular programming in utero that predisposes offspring to inflammation-related disorders (such as Alzheimer's, Parkinson's, type 2 diabetes, stroke, heart disease, and more) from the day that they are born, regardless of whether or not the offspring are obese themselves.

10 Feb 2010

ASA Effect test: A tool to identify patients who do not respond to ASA therapy

A convenient test is now available in Canada that determines if the ASA a patient is taking to prevent heart attack and stroke is working. ASA Effect(TM) is offered through LifeLabs Medical Laboratory Services and its network of collection and testing centres.

10 Feb 2010

FDA expands indication for Crestor

On Feb. 8 the U.S. Food and Drug Administration approved the cholesterol-lowering medication Crestor (rosuvastatin) for some patients who are at increased risk of heart disease but have not been diagnosed with it.

10 Feb 2010

Biogen Idec reports 2009 fourth quarter and full year earnings

Biogen Idec Inc., a global biotechnology leader in the discovery, development, manufacturing, and commercialization of innovative therapies, today announced its full year and fourth quarter 2009 results.

9 Feb 2010

High BP may predict dementia in older adults with cognitive impairment

High blood pressure appears to predict the progression to dementia in older adults with impaired executive functions (ability to organize thoughts and make decisions) but not in those with memory dysfunction, according to a report in the February issue of Archives of Neurology, one of the JAMA/Archives journals.

9 Feb 2010

Health hazards: Clinging tobacco smoke reacts with nitrous acid and produces dangerous carcinogens

Nicotine in third-hand smoke, the residue from tobacco smoke that clings to virtually all surfaces long after a cigarette has been extinguished, reacts with the common indoor air pollutant nitrous acid to produce dangerous carcinogens. This new potential health hazard was revealed in a multi-institutional study led by researchers with the Lawrence Berkeley National Laboratory (Berkeley Lab).

9 Feb 2010

Anthera Pharmaceuticals reaches agreement with the FDA on SPA for VISTA-16 clinical study

Anthera Pharmaceuticals, Inc., a privately held biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, announced today that it reached an agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for the Phase 3 clinical study named VISTA-16 (Vascular Inflammation Suppression to Treat Acute Coronary Syndrome - 16 Weeks) for its lead product candidate, A-002, an oral sPLA2 inhibitor, in combination with HMG-CoA reductase inhibitor, or statin, therapy for short-term (16-week) treatment of patients experiencing an acute coronary syndrome.

8 Feb 2010

3SBio announces Nephoxil collaboration and license agreement with Panacor Bioscience

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced a collaboration and license agreement with Panacor Bioscience Ltd. to develop and commercialize its Nephoxil(R) pharmaceutical product for the treatment of hyperphosphatemia in China.

8 Feb 2010

Workers exposed to TCE may be at higher risk of developing Parkinson's disease

Workers exposed to tricholorethylene (TCE), a chemical once widely used to clean metal such as auto parts, may be at a significantly higher risk of developing Parkinson's disease, according to a study released today that will be presented at the American Academy of Neurology's 62nd Annual Meeting in Toronto April 10 to April 17, 2010.

7 Feb 2010

Stroke News and Research

Further Reading

sanofi-aventis reports 2009 fourth-quarter and full-year net earnings

Bombarding DNA nucleotides and mammalian meat with ‘femto-neutrons’ open new path to femtomedicine

Age-related gaps in care and outcomes for stroke patients are diminishing in hospitals

QR Pharma commences clinical trial of Posiphen in early stage AD patients

American Heart Month: Spread awareness on dangers of heart disease and stroke

Study calls for improved decision-making in using feeding tubes in dementia patients

Concomitant use of dexlansoprazole and other PPIs with Plavix: TGRD U.S. initiates trial

Racial gaps persist in women's heart-health awareness

SMT Research and Development completes first two clinical cases using Shimon Embolic Filter

An inspirational story from stroke survivor

Concentric Medical's Trevo System receives regulatory approval in Europe and Canada

Maternal obesity increases offspring's risk of developing inflammation-related disorders

ASA Effect test: A tool to identify patients who do not respond to ASA therapy

FDA expands indication for Crestor

Biogen Idec reports 2009 fourth quarter and full year earnings

High BP may predict dementia in older adults with cognitive impairment

Health hazards: Clinging tobacco smoke reacts with nitrous acid and produces dangerous carcinogens

Anthera Pharmaceuticals reaches agreement with the FDA on SPA for VISTA-16 clinical study

3SBio announces Nephoxil collaboration and license agreement with Panacor Bioscience

Workers exposed to TCE may be at higher risk of developing Parkinson's disease

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News